Concepedia

Matthew Bryant

MB

Statistics

Publications

62

Citations

3.6K

H-Index

35

Active since

1981

Affiliations

National Center for Toxicological Research(Current)

United States Food and Drug Administration

Center for Drug Evaluation and Research

Matthew Bryant is an author at National Center for Toxicological Research specializing in pharmacy, pharmacology, and toxicology.

Publications per year

1981–2023

62

Publications

62

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.

Ming Liu, Matthew Bryant, Jianping Chen et al. · PubMed · 1998 · 309 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.

Matthew Bryant, Paul L. Skipper, Steven R. Tannenbaum et al. · PubMed · 1987 · 256 citations

Pharmacy, Biochemistry, Toxicology +12

Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.

Matthew Bryant, Paolo Vineis, Paul L. Skipper et al. · Proceedings of the National Academy of Sciences · 1988 · 192 citations · Full text

Public Health, Biochemistry, Toxicology +14

Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90

K. Barry Delclos, Luísa Camacho, Sherry M. Lewis et al. · Toxicological Sciences · 2014 · 164 citations · Full text

Pharmacy, Endocrinology, Toxicology +17

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

Taofeek K. Owonikoko, Huifeng Niu, Kristiaan Nackaerts et al. · Journal of Thoracic Oncology · 2019 · 147 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 62